Literature DB >> 19617222

Regulation of the endothelial cell cycle by the ubiquitin-proteasome system.

Pasquale Fasanaro1, Maurizio C Capogrossi, Fabio Martelli.   

Abstract

Degradation of poly-ubiquitinated proteins by the 26S-proteasome complex represents a crucial quantitative control mechanism. The ubiquitin-proteasome system (UPS) plays a pivotal role in the complex molecular network regulating the progression both between and within each cell-cycle phase. Two major complexes are involved: the SKP1-CUL1-F-box-protein complex (SCF) and the anaphase-promoting complex/cyclosome (APC/C). Notwithstanding structural similarities, SCF and APC/C display different cellular functions and mechanisms of action. SCF modulates all cell-cycle stages and plays a prominent role at G1/S transition mainly through three regulatory subunits: Skp2, Fbw7, and beta-TRCP. APC/C, regulated by Cdc20 or Cdh1 subunits, has a crucial role in mitosis. In this review, we will describe how the endothelial cell cycle is regulated by the UPS. We will illustrate the principal SCF- and APC/C-dependent molecular mechanisms that modulate cell growth, allowing a unidirectional cell-cycle progression. Then, we will focus our attention on UPS modulation by oxidative stress, a pathogenic stimulus that causes endothelial dysfunction and is involved in numerous cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617222     DOI: 10.1093/cvr/cvp244

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

1.  E3Net: a system for exploring E3-mediated regulatory networks of cellular functions.

Authors:  Youngwoong Han; Hodong Lee; Jong C Park; Gwan-Su Yi
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

2.  Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells.

Authors:  Zaiming Lu; Qiyong Guo; Aizhong Shi; Feng Xie; Qingjie Lu
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

Review 3.  Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.

Authors:  J Wei; Z Liu; J He; Q Liu; Y Lu; S He; B Yuan; J Zhang; Y Ding
Journal:  Clin Transl Oncol       Date:  2021-10-13       Impact factor: 3.405

Review 4.  The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.

Authors:  Huabo Su; Xuejun Wang
Journal:  Cardiovasc Res       Date:  2009-08-20       Impact factor: 10.787

5.  Erythropoietic defect associated with reduced cell proliferation in mice lacking the 26S proteasome shuttling factor Rad23b.

Authors:  Steven Bergink; Arjan F Theil; Wendy Toussaint; Iris M De Cuyper; Divine I Kulu; Thomas Clapes; Reinier van der Linden; Jeroen A Demmers; Eric P Mul; Floris P van Alphen; Jurgen A Marteijn; Teus van Gent; Alex Maas; Catherine Robin; Sjaak Philipsen; Wim Vermeulen; James R Mitchell; Laura Gutiérrez
Journal:  Mol Cell Biol       Date:  2013-07-29       Impact factor: 4.272

6.  The E3 ubiquitin ligase APC/CCdh1 degrades MCPH1 after MCPH1-βTrCP2-Cdc25A-mediated mitotic entry to ensure neurogenesis.

Authors:  Xiaoqian Liu; Wen Zong; Tangliang Li; Yujun Wang; Xingzhi Xu; Zhong-Wei Zhou; Zhao-Qi Wang
Journal:  EMBO J       Date:  2017-11-17       Impact factor: 11.598

7.  Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle.

Authors:  Raluca Rusovici; Chirag J Patel; Kakarla V Chalam
Journal:  Clin Ophthalmol       Date:  2013-02-13

Review 8.  The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression.

Authors:  Tingting Zou; Zhenghong Lin
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

9.  Evolutionary conservation and network structure characterize genes of phenotypic relevance for mitosis in human.

Authors:  Marek Ostaszewski; Serge Eifes; Antonio del Sol
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

10.  Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

Authors:  W Li; M Liu; Y Feng; Y-F Xu; Y-F Huang; J-P Che; G-C Wang; X-D Yao; J-H Zheng
Journal:  Br J Cancer       Date:  2014-07-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.